422 related articles for article (PubMed ID: 16631941)
21. Dermatitis herpetiformis: close to unravelling a disease.
Kárpáti S
J Dermatol Sci; 2004 Apr; 34(2):83-90. PubMed ID: 15033190
[TBL] [Abstract][Full Text] [Related]
22. Dermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathology.
Zone JJ; Schmidt LA; Taylor TB; Hull CM; Sotiriou MC; Jaskowski TD; Hill HR; Meyer LJ
J Immunol; 2011 Apr; 186(7):4474-80. PubMed ID: 21335491
[TBL] [Abstract][Full Text] [Related]
23. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease.
Collin P; Salmi TT; Hervonen K; Kaukinen K; Reunala T
Ann Med; 2017 Feb; 49(1):23-31. PubMed ID: 27499257
[TBL] [Abstract][Full Text] [Related]
24. Dermatitis herpetiformis.
Otley C; Hall RP
Dermatol Clin; 1990 Oct; 8(4):759-69. PubMed ID: 2249367
[TBL] [Abstract][Full Text] [Related]
25. Detection of antibodies to epidermal transglutaminase but not tissue transglutaminase in Japanese patients with dermatitis herpetiformis.
Asano Y; Makino T; Ishida W; Furuichi M; Shimizu T
Br J Dermatol; 2011 Apr; 164(4):883-4. PubMed ID: 21114479
[No Abstract] [Full Text] [Related]
26. Immunoglobulin G (IgG) anti-tissue transglutaminase antibodies used as markers for IgA-deficient celiac disease patients.
Dahlbom I; Olsson M; Forooz NK; Sjöholm AG; Truedsson L; Hansson T
Clin Diagn Lab Immunol; 2005 Feb; 12(2):254-8. PubMed ID: 15699419
[TBL] [Abstract][Full Text] [Related]
27. [Guideline 'Coeliac disease and dermatitis herpetiformis'].
Nieuwenhuis WP; Kneepkens CM; Houwen RH; de Beer HJ; Mulder CJ; Mearin ML
Ned Tijdschr Geneeskd; 2010; 154():A1904. PubMed ID: 21029498
[TBL] [Abstract][Full Text] [Related]
28. TG6 Auto-Antibodies in Dermatitis Herpetiformis.
Hadjivassiliou M; Reunala T; Hervonen K; Aeschlimann P; Aeschlimann D
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32967363
[TBL] [Abstract][Full Text] [Related]
29. Dermatitis Herpetiformis: Novel Perspectives.
Antiga E; Maglie R; Quintarelli L; Verdelli A; Bonciani D; Bonciolini V; Caproni M
Front Immunol; 2019; 10():1290. PubMed ID: 31244841
[TBL] [Abstract][Full Text] [Related]
30. Anti-endomysial antibodies. A serologic marker of dermatitis herpetiformis.
Accetta P; Kumar V; Beutner EH; Chorzelski TP; Helm F
Arch Dermatol; 1986 Apr; 122(4):459-62. PubMed ID: 3513713
[TBL] [Abstract][Full Text] [Related]
31. Circulating autoantibodies to tissue transglutaminase differentiate patients with dermatitis herpetiformis from those with linear IgA disease.
Rose C; Dieterich W; Bröcker EB; Schuppan D; Zillikens D
J Am Acad Dermatol; 1999 Dec; 41(6):957-61. PubMed ID: 10570380
[TBL] [Abstract][Full Text] [Related]
32. Two-year follow-up of anti-transglutaminase autoantibodies among celiac children on gluten-free diet: comparison of IgG and IgA.
Martín-Pagola A; Ortiz-Paranza L; Bilbao JR; de Nanclares GP; Estevez EP; Castaño L; Vitoria JC
Autoimmunity; 2007 Mar; 40(2):117-21. PubMed ID: 17364503
[TBL] [Abstract][Full Text] [Related]
33. Isotype distribution and serial levels of antibodies reactive with dietary protein antigens in dermatitis herpetiformis.
Barnes RM; Lewis-Jones MS
J Clin Lab Immunol; 1989 Oct; 30(2):87-91. PubMed ID: 2641534
[TBL] [Abstract][Full Text] [Related]
34. Recognition of epidermal transglutaminase by IgA and tissue transglutaminase 2 antibodies in a rare case of Rhesus dermatitis.
Sestak K; Mazumdar K; Midkiff CC; Dufour J; Borda JT; Alvarez X
J Vis Exp; 2011 Dec; (58):. PubMed ID: 22214930
[TBL] [Abstract][Full Text] [Related]
35. Clinical and immunopathological features of 159 patients with dermatitis herpetiformis: an Italian experience.
Antiga E; Verdelli A; Calabrò A; Fabbri P; Caproni M
G Ital Dermatol Venereol; 2013 Apr; 148(2):163-9. PubMed ID: 23588141
[TBL] [Abstract][Full Text] [Related]
36. Dermatitis herpetiformis: pathognomonic transglutaminase IgA deposits in the skin and excellent prognosis on a gluten-free diet.
Reunala T; Salmi TT; Hervonen K
Acta Derm Venereol; 2015 Nov; 95(8):917-22. PubMed ID: 26059085
[TBL] [Abstract][Full Text] [Related]
37. Small bowel transglutaminase 2-specific IgA deposits in dermatitis herpetiformis.
Salmi TT; Hervonen K; Laurila K; Collin P; Mäki M; Koskinen O; Huhtala H; Kaukinen K; Reunala T
Acta Derm Venereol; 2014 Jul; 94(4):393-7. PubMed ID: 24352382
[TBL] [Abstract][Full Text] [Related]
38. Reticulin and endomysial antibodies in bullous diseases. Comparison of specificity and sensitivity.
Kumar V; Hemedinger E; Chorzelski TP; Beutner EH; Valeski JE; Kowalewski C
Arch Dermatol; 1987 Sep; 123(9):1179-82. PubMed ID: 3307639
[TBL] [Abstract][Full Text] [Related]
39. IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease.
Chorzelski TP; Beutner EH; Sulej J; Tchorzewska H; Jablonska S; Kumar V; Kapuscinska A
Br J Dermatol; 1984 Oct; 111(4):395-402. PubMed ID: 6435666
[TBL] [Abstract][Full Text] [Related]
40. Serum reactivity in dermatitis herpetiformis: an international multicentre study.
Boch K; Heck F; Hammers CM; Antiga E; Caproni M; Juhl D; Goletz S; Horváth ON; Huilaja L; Khil'chenko S; Sina C; Tasanen K; Vassileva S; Schlumberger W; Zillikens D; Shahid M; Drenovska K; Zone JJ; Koszorú K; Fechner K; Dähnrich C; König IR; Schmidt E
Clin Exp Dermatol; 2023 Dec; 49(1):53-57. PubMed ID: 37793183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
